Maternal and Neonatal Outcomes After Respiratory Syncytial Virus Prefusion F Protein Vaccination During Pregnancy: Analysis From the 2024-2025 Immunization Campaign in France.
Saved in:
| Title: | Maternal and Neonatal Outcomes After Respiratory Syncytial Virus Prefusion F Protein Vaccination During Pregnancy: Analysis From the 2024-2025 Immunization Campaign in France. |
|---|---|
| Authors: | Gabet A; EPI-PHARE, Epidemiology of Health Products (French National Agency for Medicines and Health Products Safety, and French National Health Insurance), Saint-Denis, and University of Paris-Saclay, UVSQ, University Paris-Sud, Inserm, Anti-Infective Evasion and Pharmaco-Epidemiology, CESP (Center for Research in Epidemiology and Population Health), Montigny le Bretonneux, France., Bertrand M, Jabagi MJ, Kolla E, Olié V, Zureik M |
| Source: | Obstetrics and gynecology [Obstet Gynecol] 2026 Jan 01; Vol. 147 (1), pp. 118-126. Date of Electronic Publication: 2025 Nov 13. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0401101 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-233X (Electronic) Linking ISSN: 00297844 NLM ISO Abbreviation: Obstet Gynecol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
